- Report
- October 2025
- 198 Pages
Global
From €4045EUR$4,500USD£3,463GBP
- Report
- July 2026
- 120 Pages
Global
From €4270EUR$4,750USD£3,655GBP
- Report
- July 2026
- 115 Pages
Global
From €4270EUR$4,750USD£3,655GBP
- Report
- May 2026
- 400 Pages
Global
From €4449EUR$4,949USD£3,808GBP
- Report
- July 2026
- 160 Pages
Global
From €3731EUR$4,150USD£3,193GBP
- Report
- May 2026
- 156 Pages
Global
From €3551EUR$3,950USD£3,039GBP
- Report
- May 2026
- 145 Pages
Global
From €3551EUR$3,950USD£3,039GBP
- Report
- May 2026
- 148 Pages
Global
From €3551EUR$3,950USD£3,039GBP
- Report
- May 2026
- 150 Pages
Global
From €3551EUR$3,950USD£3,039GBP
- Report
- May 2026
- 157 Pages
Global
From €3551EUR$3,950USD£3,039GBP
- Report
- May 2026
- 148 Pages
Global
From €3551EUR$3,950USD£3,039GBP
- Report
- May 2026
- 154 Pages
Global
From €3551EUR$3,950USD£3,039GBP
- Report
- May 2026
- 146 Pages
Global
From €3551EUR$3,950USD£3,039GBP
- Report
- May 2026
- 146 Pages
Global
From €3551EUR$3,950USD£3,039GBP
- Report
- May 2026
- 153 Pages
Global
From €3551EUR$3,950USD£3,039GBP
- Report
- May 2026
- 149 Pages
Global
From €3551EUR$3,950USD£3,039GBP
- Report
- October 2025
- 160 Pages
Global
From €2841EUR$3,160USD£2,431GBP
€3551EUR$3,950USD£3,039GBP
- Report
- April 2026
- 128 Pages
Global
From €3500EUR$4,171USD£3,101GBP
- Report
- February 2026
- 114 Pages
Global
From €3500EUR$4,171USD£3,101GBP
- Report
- October 2025
- 140 Pages
Global
From €4360EUR$4,850USD£3,732GBP

Leukemia is a type of cancer that affects the blood and bone marrow. It is a form of hematological malignancy, which is a cancer of the blood-forming cells. Leukemia is characterized by an abnormal increase in the number of white blood cells in the body, which can interfere with the normal functioning of the blood and bone marrow. Symptoms of leukemia can include fatigue, fever, anemia, and an enlarged spleen. Treatment for leukemia typically involves chemotherapy, radiation therapy, and/or stem cell transplantation.
There are several companies that are involved in the Leukemia market. These include pharmaceutical companies such as Novartis, Celgene, and Bristol-Myers Squibb, as well as biotechnology companies such as Gilead Sciences and Amgen. Additionally, there are a number of research organizations and academic institutions that are actively researching new treatments for leukemia. Show Less Read more